[ad_1]
Biontech could be the first company in the Western world to launch a vaccine against the coronavirus. About the research couple Özlem Türeci and Uğur Şahin, who are behind the company.
Since
Elisabeth dostert
Uğur Şahin first had to learn how the stock market works. He did so when Biontech, the company he and his wife Özlem Türeci co-founded in 2008, went public. In October 2019 the time had come. Then, Biontech was listed on the US Nasdaq technology exchange at a price of $ 15 per share. Overall, the Mainz company with the promising address at An der Goldgrube 12 was worth around three billion dollars at the time and Biontech was largely unknown. That has changed a lot since then. In the fight against the pandemic, Biontech is considered one of the great hopes. Since Tuesday, the hope is even greater that Biontech will be the first company in the Western world to bring a coronavirus vaccine to market. The company is now worth around € 21 billion, more than Deutsche Bank.
